Letter

ASCOT: a tale of two treatment regimens

BMJ 2005; 331 doi: 10.1136/bmj.331.7523.1022-a (Published 27 October 2005)
Cite this as: BMJ 2005;331:1022.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Is ASCOT-BPLA being hyped-up?

  1. Peter D Burrill, assistant director of public health (peter.burrill@chesterfieldpct.nhs.uk)
  1. Prescribing and Clinical Effectiveness, Chesterfield Primary Care Trust, Chesterfield S41 7PF

    EDITOR—McDougall et al discuss whether the small absolute differences in secondary outcomes seen in the ASCOT-BPLA study were attributable to the blood pressure differences achieved.1 They use the accompanying paper to argue that this was in fact not so.2

    However, the editorial that accompanies the ASCOT-BPLA study severely criticises this post-hoc analysis and considers that the 2.7 mm Hg …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular